Lambin
Anne Lambin, Lomme FR
Patent application number | Description | Published |
---|---|---|
20110233102 | USE OF A MATERIAL BASED ON A THERMOPLASTIC POLYMER HAVING A HIGH CONTENT OF ANTIOXIDANTS FOR PACKAGING DIANHYDROHEXITOLS - The present invention relates to the use of a packaging material based on a thermoplastic polymer for packaging a dianhydrohexitol, the packaging material comprising at least one thermoplastic polymer layer containing at least 0.1% by weight of at least one antioxidant (layer (A)), said layer (A) either being directly in contact with the dianhydrohexitol or being separated from the latter by a thermoplastic polymer layer (layer (B)) having a thickness at most equal to 150 μm, and the thermoplastic polymer of the layer (A) and/or of the layer (B) being chosen independently from polyethylene, polypropylene, ethylene/polypropylene copolymers and blends of the latter. | 09-29-2011 |
Philippe Lambin, Bousval BE
Patent application number | Description | Published |
---|---|---|
20130053392 | CARBONIC ANHYDRASE INHIBITORS - A carbonic anhydrase IX (CA IX) inhibitor which comprises a compound of general formula: R—NH—CX—NH—(CH | 02-28-2013 |
Philippe Lambin, Genappe Bousvalle BE
Patent application number | Description | Published |
---|---|---|
20130274305 | CANCER TARGETING USING CARBONIC ANHYDRASE ISOFORM IX INHIBITORS - The present invention concerns novel carbonic anhydrase IX inhibitors comprising a nitroimidazole moiety and their use in therapy of hypoxic conditions, in particular cancer treatment, especially chemotherapy and radiotherapy. The compounds of the invention have an increased specificity for the carbonic anhydrase IX enzyme compared to the art. The present invention relates to novel nitroimidazole derivates represented by formula (1). | 10-17-2013 |
20150150849 | CANCER TARGETING USING CARBONIC ANHYDRASE ISOFORM IX INHIBITORS - The present invention concerns novel carbonic anhydrase IX inhibitors comprising a nitroimidazole moiety and their use in therapy of hypoxic conditions, in particular cancer treatment, especially chemotherapy and radiotherapy. The compounds of the invention have an increased specificity for the carbonic anhydrase IX enzyme compared to the art. The present invention relates to novel nitroimidazole derivates represented by formula (1), wherein R | 06-04-2015 |
Philippe Lambin, Maastricht NL
Patent application number | Description | Published |
---|---|---|
20160078613 | Method and System for Determining a Phenotype of a Neoplasm in a Human or Animal Body - The present invention relates to a decision support system and an image analysis method for providing information for enabling determination of a phenotype of a neoplasm in a human or animal body for enabling prognostication, comprising the steps of: receiving, by a processing unit, image data of the neoplasm; and deriving, by the processing unit, a plurality of image feature parameter values from the image data, said image parameter values relating to image features associated with the neoplasm; and deriving, by said processing unit using a signature model, one or more neoplasm signature model values associated with the neoplasm from said image feature parameter values, wherein said signature model includes a functional relation between or characteristic values of said image feature parameter values for deriving said neoplasm signature model values | 03-17-2016 |